Critical appraisal:Mukai M, Oida Y, Tajima T, Kishima K, Ninomiya H, Sato S, et al 2006

From Cancer Guidelines Wiki

Risk of bias assessment: cohort study

Subject selection
"New technology" group
Selected group
Comparison group
Selected group
Comparability of groups on demographic characteristics and clinical features
Not comparable and not adjusted for differences
Measurement of outcomes
Outcome measures blind to technology used
No, but objective measures used
Same method of measurement used across comparison groups
Completeness of follow-up
Was follow-up complete and were all patients included in the analysis?
No or not described
Overall risk of bias
High risk of bias Additional comments: Please replace this text and include any additional comments in regards to your risk of bias rating

Jutta's tick icon.png This appraisal has been completed.

Mukai M, Oida Y, Tajima T, Kishima K, Ninomiya H, Sato S, et al. Alternating hepatic arterial infusion and systemic chemotherapy for stage IV colorectal cancer with synchronous liver metastasis. Oncol Rep 2006 Oct;16(4):865-70 Available from:
Assigned to
Topic area
Guidelines:Colorectal cancer
Clinical question
Form:Quality appraisal cohort

Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment